272 related articles for article (PubMed ID: 7861408)
1. Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin.
Posner GH; McGarvey DJ; Oh CH; Kumar N; Meshnick SR; Asawamahasadka W
J Med Chem; 1995 Feb; 38(4):607-12. PubMed ID: 7861408
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
Cumming JN; Wang D; Park SB; Shapiro TA; Posner GH
J Med Chem; 1998 Mar; 41(6):952-64. PubMed ID: 9526569
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers.
Posner GH; Ploypradith P; Parker MH; O'Dowd H; Woo SH; Northrop J; Krasavin M; Dolan P; Kensler TW; Xie S; Shapiro TA
J Med Chem; 1999 Oct; 42(21):4275-80. PubMed ID: 10543871
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of the antimalarial agent artemisinin. 3. Total synthesis of (+)-13-carbaartemisinin and related tetra- and tricyclic structures.
Avery MA; Fan P; Karle JM; Bonk JD; Miller R; Goins DK
J Med Chem; 1996 Apr; 39(9):1885-97. PubMed ID: 8627612
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in vivo antimalarial screening of new, potential preclinical antimalarial candidates.
Avery MA; Alvim-Gaston M; Vroman JA; Wu B; Ager A; Peters W; Robinson BL; Charman W
J Med Chem; 2002 Sep; 45(19):4321-35. PubMed ID: 12213073
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and antimalarial activities of N-substituted 11-azaartemisinins.
Torok DS; Ziffer H; Meshnick SR; Pan XQ; Ager A
J Med Chem; 1995 Dec; 38(26):5045-50. PubMed ID: 8544181
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action.
Cumming JN; Ploypradith P; Posner GH
Adv Pharmacol; 1997; 37():253-97. PubMed ID: 8891104
[No Abstract] [Full Text] [Related]
8. Structure-activity relationships of the antimalarial agent artemisinin. 5. Analogs of 10-deoxoartemisinin substituted at C-3 and C-9.
Avery MA; Mehrotra S; Johnson TL; Bonk JD; Vroman JA; Miller R
J Med Chem; 1996 Oct; 39(21):4149-55. PubMed ID: 8863791
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin.
Avery MA; Gao F; Chong WK; Mehrotra S; Milhous WK
J Med Chem; 1993 Dec; 36(26):4264-75. PubMed ID: 8277509
[TBL] [Abstract][Full Text] [Related]
10. Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether.
O'Neill PM; Searle NL; Kan KW; Storr RC; Maggs JL; Ward SA; Raynes K; Park BK
J Med Chem; 1999 Dec; 42(26):5487-93. PubMed ID: 10639291
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of the antimalarial agent artemisinin. 2. Effect of heteroatom substitution at O-11: synthesis and bioassay of N-alkyl-11-aza-9-desmethylartemisinins.
Avery MA; Bonk JD; Chong WK; Mehrotra S; Miller R; Milhous W; Goins DK; Venkatesan S; Wyandt C; Khan I
J Med Chem; 1995 Dec; 38(26):5038-44. PubMed ID: 8544180
[TBL] [Abstract][Full Text] [Related]
12. Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX.
Delhaes L; Blot C; Berry L; Maciejewski LA; Camus D; Brocard JS; Dive D
Bioorg Med Chem; 2000 Dec; 8(12):2739-45. PubMed ID: 11131165
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of the antimalarial agent artemisinin. 4. Effect of substitution at C-3.
Avery MA; Mehrotra S; Bonk JD; Vroman JA; Goins DK; Miller R
J Med Chem; 1996 Jul; 39(15):2900-6. PubMed ID: 8709124
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of benzylamino and alkylamino ether analogues of artemisinin.
O'Neill PM; Bishop LP; Storr RC; Hawley SR; Maggs JL; Ward SA; Park BK
J Med Chem; 1996 Oct; 39(22):4511-4. PubMed ID: 8893847
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-substituted phenyl)-4(R or S)-[10(alpha or beta)-dihydroartemisininoxy]butyric acids.
Lin AJ; Zikry AB; Kyle DE
J Med Chem; 1997 Apr; 40(9):1396-400. PubMed ID: 9135037
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimalarial activities of fluoroalkyl derivatives of dihydroartemisinin.
Thanh Nga TT; Ménage C; Bégué JP; Bonnet-Delpon D; Gantier JC; Pradines B; Doury JC; Thac TD
J Med Chem; 1998 Oct; 41(21):4101-8. PubMed ID: 9767645
[TBL] [Abstract][Full Text] [Related]
17. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
18. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation.
Posner GH; Cumming JN; Woo SH; Ploypradith P; Xie S; Shapiro TA
J Med Chem; 1998 Mar; 41(6):940-51. PubMed ID: 9526568
[TBL] [Abstract][Full Text] [Related]
19. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family.
Posner GH; Parker MH; Northrop J; Elias JS; Ploypradith P; Xie S; Shapiro TA
J Med Chem; 1999 Jan; 42(2):300-4. PubMed ID: 9925735
[TBL] [Abstract][Full Text] [Related]
20. Endoperoxides as potential antimalarial agents.
Kepler JA; Philip A; Lee YW; Musallam HA; Carroll FI
J Med Chem; 1987 Aug; 30(8):1505-9. PubMed ID: 3302259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
